182 related articles for article (PubMed ID: 34440666)
1. Optimizing Active Tumor Targeting Biocompatible Polymers for Efficient Systemic Delivery of Adenovirus.
Lee JY; Hong JW; Thambi T; Yoon AR; Choi JW; Li Y; Bui QN; Lee DS; Yun CO
Cells; 2021 Jul; 10(8):. PubMed ID: 34440666
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
Kwon OJ; Kang E; Choi JW; Kim SW; Yun CO
J Control Release; 2013 Aug; 169(3):257-65. PubMed ID: 23562633
[TBL] [Abstract][Full Text] [Related]
3. Tuning Surface Charge and PEGylation of Biocompatible Polymers for Efficient Delivery of Nucleic Acid or Adenoviral Vector.
Choi JW; Kim J; Bui QN; Li Y; Yun CO; Lee DS; Kim SW
Bioconjug Chem; 2015 Aug; 26(8):1818-29. PubMed ID: 26158495
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
[TBL] [Abstract][Full Text] [Related]
5. Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy.
Park Y; Kang E; Kwon OJ; Hwang T; Park H; Lee JM; Kim JH; Yun CO
J Control Release; 2010 Nov; 148(1):75-82. PubMed ID: 20637814
[TBL] [Abstract][Full Text] [Related]
6. Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.
Moon CY; Choi JW; Kasala D; Jung SJ; Kim SW; Yun CO
Biomaterials; 2015 Feb; 41():53-68. PubMed ID: 25522965
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model.
Yoon AR; Kasala D; Li Y; Hong J; Lee W; Jung SJ; Yun CO
J Control Release; 2016 Jun; 231():2-16. PubMed ID: 26951927
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.
Kim J; Li Y; Kim SW; Lee DS; Yun CO
Biomaterials; 2013 Jun; 34(19):4622-31. PubMed ID: 23541109
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy.
Choi JW; Nam JP; Nam K; Lee YS; Yun CO; Kim SW
Biomacromolecules; 2015 Jul; 16(7):2132-43. PubMed ID: 26096567
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration.
Choi JW; Dayananda K; Jung SJ; Lee SH; Kim D; Hu J; Bae YH; Yun CO
Acta Biomater; 2015 Dec; 28():86-98. PubMed ID: 26365317
[TBL] [Abstract][Full Text] [Related]
11. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
12. Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model.
Jung SJ; Kasala D; Choi JW; Lee SH; Hwang JK; Kim SW; Yun CO
Biomacromolecules; 2015 Jan; 16(1):87-96. PubMed ID: 25400213
[TBL] [Abstract][Full Text] [Related]
13. Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression.
Lee CH; Kasala D; Na Y; Lee MS; Kim SW; Jeong JH; Yun CO
Biomaterials; 2014 Jul; 35(21):5505-16. PubMed ID: 24731708
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo.
Han SY; Lee YJ; Jung HI; Lee SW; Lim SJ; Hong SH; Jeong JS
Exp Mol Med; 2008 Aug; 40(4):427-34. PubMed ID: 18779655
[TBL] [Abstract][Full Text] [Related]
15. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
16. Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration.
Kim PH; Kim J; Kim TI; Nam HY; Yockman JW; Kim M; Kim SW; Yun CO
Biomaterials; 2011 Dec; 32(35):9328-42. PubMed ID: 21924767
[TBL] [Abstract][Full Text] [Related]
17. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
[TBL] [Abstract][Full Text] [Related]
18. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
[TBL] [Abstract][Full Text] [Related]
19. Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.
Kim J; Nam HY; Kim TI; Kim PH; Ryu J; Yun CO; Kim SW
Biomaterials; 2011 Aug; 32(22):5158-66. PubMed ID: 21531456
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus.
Kasala D; Lee SH; Hong JW; Choi JW; Nam K; Chung YH; Kim SW; Yun CO
Biomaterials; 2017 Nov; 145():207-222. PubMed ID: 28869866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
